The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
NCT Number: NCT01578694
Magnetic resonance imaging (MRI) has proven to be one of the best ways to image articular cartilage. A tremendous amount of research has focused on cartilage imaging with an emphasis of early-osteoarthritis (OA) characterization. One of the techniques which has shown great promise is the imaging technique called T1ρ . The advantage of this pulse sequence is that it is sensitive to proteoglycans (PG), a major macromolecule degraded in OA. The study objective is to determine if T1ρ can acutely assess PG content in femoroacetabular impingement (FAI) which may allow physicians to differentiate between normal and early-OA cartilage states in FAI patients.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Ottawa, Ontario, K1H 8L6, Canada
Magnetic resonance imaging (MRI) is one of the best ways to image articular cartilage. One of the techniques which has shown great promise is the imaging technique called T1ρ (T1-rho). T1ρ is a modified pulse sequence from the standard T1 sequence used in the clinical MRI. Because the initial phases of arthritis occur at the molecular level, the main advantage of the T1ρ pulse sequence is that it is sensitive to proteoglycan. Proteoglycan is a molecule that is important to cartilage structure, and is lost as osteoarthritis develops. If we can show that this non-invasive tool can accurately assess cartilage damage and levels of proteoglycan, the clinical applications are numerous. The results can potentially help determine optimal surgical techniques and timing of surgical intervention to halt or slow the progression of arthritis, and will assist in the study of the effects of FAI and the success of the surgery performed to correct FAI.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
T1 rho MRI is a modified pulse sequence from the standard T1 sequence used in the clinical MRI.
Time frame: Pre-op (within 6 weeks prior to surgery)
To provide a detailed quantitative assessment of the sensitivity of T1rho in the characterization of proteoglycan depletion in patients with or without femoroacetabular impingement.
Ottawa Hospital Research Institute
Other
Characterization of Proteoglycan Depletion in Femoroacetabular Impingement With T1ρ MRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03494660
Avascular Necrosis of Hip, Bone Cysts
Rancho Mirage, California, United States
View Trial DetailsNCT02408276
Femoracetabular Impingement, Femoroacetabular Impingement
New York, United States
View Trial DetailsNCT05031390
Femoracetabular Impingement, Femoroacetabular Impingement
Horsens, Danmark, Denmark
View Trial DetailsNCT04822571
Femoracetabular Impingement, Femoroacetabular Impingement
Leuven, Vlaams-Brabant, Belgium
View Trial Details